typing service - picture document to words document.
U world cardiac and leadership 1
Assessment for PAD includes :-
HEART: decreased peripheral
pulses
DERM: cool shiny skin, hair loss,
ulcers, gangrene, impaired
sensation
MISC.: intermittent claudication
S: shiney skin
H: hair loss to the extremity
I: intermittent claudication
N: nasty ulcers
E: extremities will be cool
Causes of PAD includes Causes:
❖ Arteriosclerosis
❖ Raynauds
❖ Buerger’s
❖ Smoking
❖ Diabetes
❖ Hyperlipidemia
❖ Hypertension
❖ Obesity
❖ Sedentary lifestyle
❖ Age
Nursing interventions for PAD includes :-
❖ Check extremities for
paleness, coolness or
necrosis
❖ Meticulous foot care: warm
water, gently dry
thoroughly, use lubricants,
wear clean cotton socks
❖ Do not cross legs
❖ Regular exercise
❖ No smoking
❖ Weight loss
Nursing Teaching for PAD includes:-
❖ Educate the client to
maintain aseptic technique.
❖ Instruct the client on how
to administer IV antibiotics.
❖ Have the client record
temp daily for six weeks.
❖ Encourage oral hygeine for
six weeks with a soft bristle
toothbrush 2x daily.
❖ Have the client clean any
skin lacerations and apply
antibiotic ointment.
❖ Client should inform all
HCP’s of hx of
endocarditis.
❖ Client should use
prophylactic antibiotics for
oral procedures.
❖ Tech the client the signs
and symptoms of emboli
and HF.
Medical treatment for PAD includes:-
❖ Arterial bypass with
autogenous vein or
synthetic graft.
❖ Endarterectomy.
❖ Patch graft angioplasty.
❖ Amputation.
A patient is being discharged following insertion of a permanent pacemaker. The nurse determines that the patient requires further instruction on safety precaution after the following statement:
Overview
A new pacemaker requires limitation of physical activity, including no lifting, pulling, or pushing more than 5 pounds, so the patient will need to be educated further if they speak of lifting something greater than 5 pounds.
Learning Outcomes
A new pacemaker requires limitation of physical activity, including no lifting, pulling, or pushing more than 5 pounds. Other limitations include limiting tasks like sweeping in repetitive motions, keeping the area free from pressure (such as tight clothing or suspenders), and not raising the arm on the affected side above the level of the heart for the first few weeks. The pacemaker insertion site may be bruised, swollen, tender, and instructions may include gentle washing of incision site, and not applying lotion or powder.
Heparin
64. A client with atrial fibrillation who is receiving maintenance therapy of
warfarin sodium has a prothrombin time (PT) of 35 seconds. On the basis of
these laboratory values, the nurse anticipates which prescription?
1. Adding a dose of heparin sodium
2. Holding the next dose of warfarin
3. Increasing the next dose of warfarin
4. Administering the next dose of warfarin
64. Answer: 2
Rationale: The normal PT is 11 to 12.5 seconds (conventional therapy and SI
units). A therapeutic PT level is 1.5 to 2 times higher than the normal level. Because
the value of 35 seconds is high, the nurse should anticipate that the client would not
receive further doses at this time. Therefore, the prescriptions noted in the remaining
options are incorrect
68. A client is receiving a continuous intravenous infusion of heparin sodium to
treat deep vein thrombosis. The client’s activated partial thromboplastin time
(aPTT) is 65 seconds. The nurse anticipates that which action is needed?
1. Discontinuing the heparin infusion
2. Increasing the rate of the heparin infusion
3. Decreasing the rate of the heparin infusion
4. Leaving the rate of the heparin infusion as is
68. Answer: 4
Rationale: The normal aPTT varies between 30 and 40 seconds (30 and 40
seconds), depending on the type of activator used in testing. The therapeutic dose of
heparin for treatment of deep vein thrombosis is to keep the aPTT between 1.5 (45 to
60) and 2.5 (75 to 100) times normal. This means that the client’s value should not be
less than 45 seconds or greater than 100 seconds. Thus, the client’s aPTT is within the
therapeutic range and the dose should remain unchanged.
Test-Taking Strategy: Focus on the subject, the expected aPTT for a client
receiving a heparin sodium infusion. Remember that the normal range is 30 to 40
seconds and that the aPTT should be between 1.5 and 2.5 times normal when the
client is receiving heparin therapy. Simple multiplication of 1.5 and 2.5 by 30 and 40
will yield a range of 45 to 100 seconds. This client’s value is 65 seconds.
Activated partial thromboplastin time (aPTT)
1. The aPTT evaluates how well the coagulation
sequence (intrinsic clotting system) is functioning by
measuring the amount of time it takes in seconds for
recalcified citrated plasma to clot after partial
thromboplastin is added to it.
2. The test screens for deficiencies and inhibitors of all
factors, except factors VII and XIII.
3. Usually, the aPTT is used to monitor the
effectiveness of heparin therapy and screen for
4. Normal reference interval: 30 to 40 seconds
(conventional and SI units [International System of
Units]), depending on the type of activator used.
5. If the client is receiving intermittent heparin therapy,
draw the blood sample 1 hour before the next
scheduled dose.
6. Do not draw samples from an arm into which heparin
is infusing.
7. Transport specimen to the laboratory immediately.
8. Provide direct pressure to the venipuncture site for 3
to 5 minutes.
9. The aPTT should be between 1.5 and 2.5 times normal
when the client is receiving heparin therapy.
10. Elevated values occur in the following: Deficiency of
one or more of the following: factor I, II, V, or VIII;
factors IX and X; factor XI; and factor XII; hemophilia;
heparin therapy; liver disease
If the aPTT value is prolonged (longer than 100 seconds or per
agency policy) in a client receiving IV heparin therapy or in any client at
risk for thrombocytopenia, initiate bleeding precautions.
E. Prothrombin time (PT) and international normalized ratio (INR)
1. Prothrombin is a vitamin K–dependent glycoprotein
produced by the liver that is necessary for fibrin clot
formation.
2. Each laboratory establishes a normal or control value
based on the method used to perform the PT test.
3. The PT measures the amount of time it takes in
seconds for clot formation and is used to monitor
response to warfarin sodium therapy or to screen for
dysfunction of the extrinsic clotting system resulting
from liver disease, vitamin K deficiency, or
disseminated intravascular coagulation.
4. A PT value within 2 seconds (plus or minus) of the
control is considered normal.
5. The INR is a frequently used test to measure the
effects of some anticoagulants.
6. The INR standardizes the PT ratio and is calculated in
the laboratory setting by raising the observed PT ratio
to the power of the international sensitivity index
specific to the thromboplastin reagent used.
7. If a PT is prescribed, baseline specimen should be
drawn before anticoagulation therapy is started; note
the time of collection on the laboratory form.
8. Provide direct pressure to the venipuncture site for 3
to 5 minutes.
9. Concurrent warfarin therapy with heparin therapy can
lengthen the PT for up to 5 hours after dosing.
10. Diets high in green leafy vegetables can
increase the absorption of vitamin K, which shortens
the PT.
11. Orally administered anticoagulation therapy
usually maintains the PT at 1.5 to 2 times the
laboratory control value.
12. Normal reference intervals
a. PT: 11 to 12.5 seconds (conventional
and SI units)
b. INR: 0.81 to 1.20 (conventional and SI
units)
13. For both the PT and INR, elevated values occur in the
following: deficiency of one or more of the following:
factor I, II, V, VII, or X; liver disease; vitamin K
deficiency; warfarin therapy
If the PT value is longer than 25 seconds and the INR is
greater than 3.0 in a client receiving standard warfarin therapy (or per
agency policy), initiate bleeding precautions.
Thiazide diuretics (Box 53-7)
1. Description
a. Thiazide diuretics increase sodium and
water excretion by inhibiting sodium
reabsorption in the distal tubule of the
kidney.
b. Used for hypertension and peripheral
edema
c. Not effective for immediate diuresis
d. Used in clients with normal renal
function (contraindicated in clients
with renal failure)
e. Thiazide diuretics should be used with
caution in the client taking lithium,
because lithium toxicity can occur, and
in the client taking digoxin,
corticosteroids, or hypoglycemic
medications.
2. Side and adverse effects
a. Hypercalcemia, hyperglycemia,
hyperuricemia
b. Hypokalemia, hyponatremia
c. Hypovolemia
d. Hypotension
e. Rashes
f. Photosensitivity
g. Dehydration
3. Interventions
a. Monitor vital signs.
b. Monitor weight.
c. Monitor urine output.
d. Monitor electrolytes, glucose, calcium,
blood urea nitrogen (BUN), creatinine,
and uric acid levels.
e. Check peripheral extremities for edema.
f. Monitor for signs of digoxin or lithium
toxicity if the client is taking these
medications.
g. Instruct the client to take the
medication in the morning to avoid
nocturia and sleep interruption.
h. Instruct the client in how to record the
BP.
i. Instruct the client to eat foods high in
potassium.
j. Instruct the client in how to take
potassium supplements if prescribed.
k. Instruct the client to take medication
with food to avoid gastrointestinal
upset.
l. Instruct the client to change positions
slowly to prevent orthostatic
hypotension.
m. Instruct the client to use sunscreen
when in direct sunlight because of
increased photosensitivity.
n. Instruct the client with diabetes
mellitus to have the blood glucose
level checked periodically.
c. Hypovolemia
d. Hypotension
e. Rashes
f. Photosensitivity
g. Dehydration
3. Interventions
a. Monitor vital signs.
b. Monitor weight.
c. Monitor urine output.
d. Monitor electrolytes, glucose, calcium,
blood urea nitrogen (BUN), creatinine,
and uric acid levels.
e. Check peripheral extremities for edema.
f. Monitor for signs of digoxin or lithium
toxicity if the client is taking these
medications.
g. Instruct the client to take the
medication in the morning to avoid
nocturia and sleep interruption.
h. Instruct the client in how to record the
BP.
i. Instruct the client to eat foods high in
potassium.
j. Instruct the client in how to take
potassium supplements if prescribed.
k. Instruct the client to take medication
with food to avoid gastrointestinal
upset.
l. Instruct the client to change positions
slowly to prevent orthostatic
hypotension.
m. Instruct the client to use sunscreen
when in direct sunlight because of
increased photosensitivity.
n. Instruct the client with diabetes
mellitus to have the blood glucose
level checked periodically.
Cardiac Arrhythmias:
Normal sinus rhythm- Peaks of p waves are evenly spaced
V-fib- Chaotic squiggly line. No pattern
V-tach- Sharp peak & jags. There's a pattern
Asystole- Flat line
QRS depolarization- Answer will always be ventricular
P wave- Answer will always be atrial
Lack of a P wave- Answer will always be ventricular
A lack of QRS- Asystole
A-flutter- Saw tooth
Chaotic is always the word used to describe fibrillation
Bizarre is always the word used for tachycardia
Low Priority:
Premature ventricular contraction (PVC)
A bunch of PVC’s is like a short run of V-Tach
Moderate Priority:
If more than 6 PVC’s in a minute or row and/or if PVC falls on the T wave of the previous beat. They never are high priority!
Potentially Life Threatening:
V-Tach- Pt has a pulse
Lethal Priority: Kills you in 8 mins or less
Asystole- No pulse
V-fib- No pulse
Treatment:
Supra Ventricular (Atrial) → ABCD’s
Adenocard (Adenosine):
Push in less then 8 secs
Don't worry about Asystole
When it comes to IV push, when you don’t know go slow
Beta blockers (ending in “lol”)
Just like CCB’s, same treatment, same side effects
Calcium channel blockers
Better for asthmatics
Digoxin/Digitalis (Lanoxin)
V-fib → D-fib
Asystole → Epinephrine & Atropine (In that order if Epi doesn’t work)
PVC’s & V-Tach → Use Amiodarone for Ventricular
Various interventions have been utilized for prophylaxis of venous thromboembolism. These include mechanical devices such as graduated compression stockings (GCS), intermittent pneumatic compression (IPC) devices, and pharmacologic agents such as unfractionated heparin, low-molecular-weight heparin. Anticoagulants, including injectables such as heparin or low molecular weight heparin, or tablets such as apixaban, dabigatran, rivaroxaban, edoxaban and warfarin (also called direct-acting oral anticoagulants or DOACs). These medications are used for a number of months.